Dr Rafiqul Islam

MBBS MRCP FRCR


Special clinical interest in colorectal, lung and CUP.

LANGUAGES

English, Bengali, Urdu, Hindi

Professional profile

Dr Islam, Consultant Clinical Oncologist specialised in treating Colorectal, Lung and Cancer of Unknown Primary. He completed his Specialist Oncology training at Royal Marsden Hospital and Guy’s Hospital and obtained his Diploma in Oncology from Institute of Cancer Research (ICR), London. He was awarded the Brian Wither Travel Grant and Patricia McGregor Travel Fellowship to present his work in florida,USA regarding precision Radiotherapy(SABR/SBRT).

He has successfully implemented use of SBRT for early Lung cancer and 4DCT for all radical lung radiotherapy. His special interest is in using SBRT for Lung metastasis and Oligometastatic disease. Involved in Lung and colorectal cancer trials as Principal and Co-investigator and published in peer reviewed journals.

Alongside his work as a clinical oncologist, Dr Islam has been teaching the Trainers of Tomorrow and supporting the learning of medical students.

Professional Memberships

RCR, MDDUS, ESTRO, ESMO

Year Qualified

2001

Publications

Dean J, Welsh L, Wong K, Aleksic A, Dunne E, Islam MR, Nutting C et.al. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clinical Oncology. 29 (2017) 263-273

Sacco K, Muhammad A, Saleem W, Alshaker H, Monzon L, Islam MR, Pchejetski D. Leptomeningeal carcinomatosis as primary presentation of relapse in breast cancer (review). 2016 Aug;12(2):779-782.Oncology Letters. Epub 2016 Jun 16. DOI:10.3892/ol.2016.4745

Dean J, Welsh L, Mcquaid D, Wong K, Aleksic A, Dunne E, Islam MR, Nutting C et.al. Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. Radiotherapy and Oncology.2016 Apr; 119(1): 166–171.Epub 2016 Feb 19. DOI: http://dx.doi.org/10.1016/j.radonc.2016.02.022

Kunene V, Miscoria M, Pirrie S, Islam MR, Afshar M, Porfiri E. Sarcomatoid Renal Cell Carcinoma: Clinical Outcome and Survival After Treatment with Sunitinib. Clinical Genitourinary Cancer. 2014 Aug;12(4): 251–5. Epub 2013 Dec 27.DOI: 10.1016/j.clgc.2013.12.001.

Nimalasena S, Lopez-Campos F, Islam M, Bedford M, Hawkins M, Ahmed M. Report of outcomes with Volumetric Arc Modulated Radiotherapy (VMAT) for thoracic tumours. Poster number: EP1034.2nd ESTRO Forum, Geneva 2013 – Switzerland

Islam R, Lander F, Newbold K. Review of compliance with guidelines for risk stratification in low risk thyroid cancer at the Royal Marsden Hospital. Published as Abstract. Clinical ONCOLOGY. 2017 June;29(Supplement 1): S8

Any Outcome Measures

Stage III Lung cancer treatment and outcome in Essex, presented at Lung AGM’18

Specialities

  • Oncology

Centres